Valmark Advisers, Inc.
Source: SEC Form 13F · as of Mar 2026Valmark Advisers, Inc. holds 24 biotech & pharma companies tracked by BioSniper, totaling $33.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$33.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 23,705 | $5.8M |
| LLYELI LILLY & Co | 5,774 | $5.3M |
| MRKMerck & Co., Inc. | 28,341 | $3.4M |
| AMGNAMGEN INC | 8,726 | $3.1M |
| ABBVAbbVie Inc. | 11,030 | $2.4M |
| ABTABBOTT LABORATORIES | 18,241 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,733 | $1.6M |
| IDXXIDEXX LABORATORIES INC /DE | 2,188 | $1.2M |
| NVSNovartis AG | 7,977 | $1.2M |
| PFEPFIZER INC | 39,369 | $1.1M |
| PMPhilip Morris International Inc | 5,462 | $903K |
| MCKMcKesson Corporation | 992 | $858K |
| LQDALiquidia Corp | 20,546 | $775K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3,000 | $518K |
| GILDGILEAD SCIENCES, INC. | 3,283 | $458K |
| CORCencora Inc. | 1,428 | $449K |
| CAHCardinal Health Inc. | 2,112 | $446K |
| BMYBRISTOL MYERS SQUIBB CO | 6,730 | $408K |
| GMOptec International, Inc. | 5,195 | $387K |
| TARSTarsus Pharmaceuticals, Inc. | 5,500 | $386K |
| ELVElevance Health Inc. | 1,291 | $378K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,907 | $216K |
| ZTSZoetis Inc. | 1,747 | $207K |
| CELUCelularity Inc. | 49,983 | $66K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.